Guaifenesin/Hydrocodone Tartrate/Pseudoephedrine Hydrochloride

愈创甘油醚/酒石酸氢可酮/盐酸伪麻黄碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGuaifenesin/Hydrocodone Tartrate/Pseudoephedrine Hydrochloride
Drug Alias Name酒石酸氢可酮/盐酸伪麻黄碱/愈创甘油醚Hydrocodone Tartrate/Guaifenesin/Pseudoephedrine HydrochlorideHydrocodone Tartrate/Pseudoephedrine Hydrochloride/Guaifenesin愈创甘油醚酒石酸氢可酮盐酸伪麻黄碱Guaifenesin and Hydrocodone Tartrate and Pseudoephedrine Hydrochloride +[6] 
ClassificationSmall molecules
Mechanisms of ActionAlpha adrenergic receptor agonistsOpioid receptors agonists
TargetsOpioid receptorsAlpha adrenergic receptor
Therapy Area/IndicationsHyperemiaCoughNasal Obstruction +[7] 
Global Approved IndicationsNasal ObstructionCommon Cold
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2015/05/14
Country/TerritoryUnited StatesMainland China
CombinationsYes Pseudoephedrine HydrochlorideHydrocodone BitartrateGuaifenesin
Global Highest StatusWithdrawn
Highest Status in ChinaPending
Originator CompaniesMission Pharmacal Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChartwell Rx Sciences LlcSichuan Antibiotic Industry Research Institute Co LtdShenzhen Zhijun Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperemiaCoughNasal Obstruction +[7] 

Other Information

ATC CodeN/A
Related LinksN/A